Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus

被引:13
|
作者
Fang, Mingli [1 ]
Li, Jianli [2 ,3 ]
Wang, Hua [1 ]
Yang, Ming [4 ]
Zhang, Yongsheng [1 ]
Zhou, Lei [1 ]
Wei, Hongfei [1 ]
Yang, Guang [1 ]
Yu, Yue
Wei, Xuefeng [5 ]
Yu, Yongli
Wang, Liying [1 ]
Wan, Min [1 ]
机构
[1] Jilin Univ, Dept Mol Biol, Norman Bethune Coll Med, Changchun 130021, Peoples R China
[2] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China
[3] Tianjin Ringpu Biotechnol Co Ltd, Natl Certified Enterprise Tech Ctr, Tianjin 300300, Peoples R China
[4] Jilin Univ, Dept Immunol, Norman Bethune Coll Med, Changchun 130021, Peoples R China
[5] Inner Mongolia Jinyu Grp Baoling Biopharmaceut Co, Hohhot 013300, Inner Mongolia, Peoples R China
关键词
Foot and mouth disease virus; Recombinant epitope vaccine; RGD sequence of B cell epitope; VP1 capsid protein; PEPTIDE; CATTLE; VP1; IMMUNOGENICITY; PROTECTION; RESPONSES; PROTEIN; REGION;
D O I
10.1007/s10529-012-0856-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To develop recombinant epitope vaccines against foot-and-mouth disease virus (FMDV), genes coding for six recombinant proteins (rP1-rP6) consisting of different combinations of B cell and T cell epitope from VP1 capsid protein (VP1) of type O FMDV were constructed and the 3D structure of these proteins analyzed. This revealed a surface-exposed RGD sequence of B cell epitopes in all six recombinant proteins as that in VP1 of FMDV and rP1, rP2 and rP4 globally mimicked the backbone conformation of the VP1. rP1, rP2 and rP4 stimulated guinea pigs to produce higher level of neutralizing antibodies capable of protecting suckling mice against FMDV challenge. rP1 stimulated cattle to produce FMDV-neutralizing antibody. The data suggest that an efficient recombinant epitope vaccine against FMDV should share local similarities with the natural VP1 of FMDV.
引用
收藏
页码:839 / 847
页数:9
相关论文
共 50 条
  • [31] Detection of Bovine Antibodies against a Conserved Capsid Epitope as the Basis of a Novel Universal Serological Test for Foot-and-Mouth Disease
    Asfor, A. S.
    Howe, N.
    Grazioli, S.
    Berryman, S.
    Parekh, K.
    Wilsden, G.
    Ludi, A.
    King, D. P.
    Parida, S.
    Brocchi, E.
    Tuthill, T. J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (06)
  • [32] The rescue and selection of thermally stable type O vaccine candidate strains of foot-and-mouth disease virus
    Gao, Ya
    Li, Pinghua
    Ma, Xueqing
    Bai, Xingwen
    Sun, Pu
    Du, Ping
    Yuan, Hong
    Cao, Yimei
    Li, Kun
    Fu, Yuanfang
    Zhang, Jing
    Bao, Huifang
    Chen, Yingli
    Li, Zhiyong
    Lu, Zengjun
    Liu, Zaixin
    Li, Dong
    ARCHIVES OF VIROLOGY, 2021, 166 (08) : 2131 - 2140
  • [33] A modern approach for epitope prediction: identification of foot-and-mouth disease virus peptides binding bovine leukocyte antigen (BoLA) class I molecules
    Pandya, Mital
    Rasmussen, Michael
    Hansen, Andreas
    Nielsen, Morten
    Buus, Soren
    Golde, William
    Barlow, John
    IMMUNOGENETICS, 2015, 67 (11-12) : 691 - 703
  • [34] Identification of a conserved linear neutralizing epitope recognized by monoclonal antibody 9A9 against serotype A foot-and-mouth disease virus
    Liang, Weifeng
    Zhou, Guohui
    Liu, Wenming
    Yang, Baolin
    Li, Chaosi
    Wang, Haiwei
    Yang, Decheng
    Ma, Wenge
    Yu, Li
    ARCHIVES OF VIROLOGY, 2016, 161 (10) : 2705 - 2716
  • [35] A 12-residue epitope displayed on phage T7 reacts strongly with antibodies against foot-and-mouth disease virus
    Wong, Chuan Loo
    Yong, Chean Yeah
    Muhamad, Azira
    Syahir, Amir
    Omar, Abdul Rahman
    Sieo, Chin Chin
    Tan, Wen Siang
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2018, 102 (09) : 4131 - 4142
  • [36] Relationship between neutralizing and opsonizing monoclonal antibodies against foot-and-mouth disease virus
    Summerfield, Artur
    Gerber, Heidi
    Schmitt, Rebeka
    Liniger, Matthias
    Grazioli, Santina
    Brocchi, Emiliana
    FRONTIERS IN VETERINARY SCIENCE, 2022, 9
  • [37] The immune response to a recombinant Lactococcus lactis oral vaccine against foot-and-mouth disease virus in mice
    Xinsheng Liu
    Linlin Qi
    Jianliang Lv
    Zhongwang Zhang
    Peng Zhou
    Zhongyuan Ma
    Yonglu Wang
    Yongguang Zhang
    Li Pan
    Biotechnology Letters, 2020, 42 : 1907 - 1917
  • [38] Lack of antiviral activity of ivermectin against foot-and-mouth disease virus serotype O in BALB/c mice
    Arshad, Sheeza
    Raza, Sohail
    Rafique, Rehan
    Altaf, Imran
    Sattar, Adeel
    MICROBIAL PATHOGENESIS, 2023, 182
  • [39] Validation of the specific isotype assay to detect antibodies against foot-and-mouth disease virus in bovine milk
    Armstrong, RM
    Mathew, ES
    Mackey, DKJ
    JOURNAL OF VIROLOGICAL METHODS, 2000, 85 (1-2) : 193 - 201
  • [40] Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice
    Borrego, Belen
    Rodriguez-Pulido, Miguel
    Mateos, Francisco
    de la Losa, Nuria
    Sobrino, Francisco
    Saiz, Margarita
    VACCINE, 2013, 31 (40) : 4375 - 4381